china
sinc
spring
fatal
outcom
infect
often
attribut
sever
pneumonia
acut
respiratori
distress
syndrom
ard
urgent
need
discov
biomark
predict
progress
diseas
fatal
outcom
potenti
lethal
flu
infect
base
sound
statist
analysi
discov
cytokin
chemokin
examin
studi
significantli
elev
plasma
sampl
patient
infect
report
first
time
level
mif
scf
hgf
highli
posit
link
diseas
sever
profil
mediat
mif
scf
hgf
independ
outcom
predictor
scientif
report
doi
peopl
eastern
china
confirm
infect
influenza
novel
avianorigin
influenza
reassort
subtyp
viru
peopl
report
death
hundr
peopl
infect
influenza
viru
report
year
clinic
characterist
patient
often
includ
fever
cough
pneumonia
acut
respiratori
distress
syndrom
ard
hypercytokinemia
report
peripher
blood
patient
patient
previou
studi
report
angiotensin
ii
level
markedli
elev
plasma
patient
infect
virus
moreov
elev
level
angiotensin
ii
biomark
outcom
infect
patient
furthermor
would
like
investig
whether
elev
cytokin
chemokin
plasma
avian
influenza
infect
patient
better
altern
biomark
infect
patient
although
dysfunct
elev
level
report
avian
influenza
infect
patient
molecul
report
limit
number
case
avail
hospit
studi
comprehens
statist
analys
recruit
patient
infect
zhejiang
jiangsu
provinc
patient
infect
swineorigin
influenza
viru
beij
period
recruit
control
infect
patient
receiv
oseltamivir
peramivir
antibiot
glucocorticoid
orand
immun
globulin
therapi
order
elimin
interfer
far
possibl
collect
plasma
begin
therapi
show
plasma
profil
hypercytokinemia
dynam
signatur
protein
includ
mif
scf
hgf
dynam
biomark
predict
fatal
outcom
among
mif
scf
hgf
predict
outcom
patient
better
angiotensin
ii
hypercytokinemia
patient
perform
multiplex
analys
cytokin
chemokin
mediat
use
plasma
sampl
mediat
previous
examin
report
inpati
infect
avian
influenza
viru
gener
hypercytokinemia
observ
plasma
patient
infect
avian
influenza
viru
plasma
patient
infect
swineorigin
influenza
viru
soiv
cohort
previou
studi
fig
supplement
figur
tabl
overal
measur
cytokin
chemokin
plasma
harvest
within
first
day
diseas
onset
patient
significantli
higher
sampl
noninfect
control
individu
fig
supplement
figur
notabl
elev
chemokin
critic
player
induct
lung
injuri
robust
among
cytokin
chemokin
measur
fig
addit
increas
level
mediat
particip
develop
thelper
thelper
thelper
cell
also
observ
fig
supplement
figur
similar
cytokinechemokin
profil
note
patient
whose
plasma
collect
second
week
day
diseas
onset
supplement
tabl
data
confirm
presenc
hypercytokinemia
also
known
cytokin
storm
patient
infect
viru
discov
novel
hypercytokinemia
factor
elev
patient
includ
mif
scf
hgf
ngf
ctack
gcsf
gmcsf
vegf
basicfgf
pdgfbb
elev
avian
influenza
infect
patient
plasma
cytokin
chemokin
level
patientsplasma
obtain
day
diseas
onset
gener
decreas
compar
level
plasma
obtain
acut
phase
diseas
result
suggest
plasma
level
cytokin
chemokin
may
relat
sever
diseas
fig
supplement
figur
cytokin
chemokin
plasma
level
correl
viral
load
plasma
sampl
obtain
patient
analyz
potenti
correl
plasma
level
elev
cytokin
chemokin
patient
viral
load
apach
ii
score
mortal
respect
determin
viral
load
use
cycl
threshold
ct
valu
hemagglutinin
ha
gene
measur
qrtpcr
previous
describ
plasma
level
mig
mif
hgf
neg
correl
ct
valu
gene
thu
posit
correl
viral
load
week
week
diseas
onset
tabl
plasma
level
scf
nerv
growth
factor
ngf
neg
correl
ct
valu
gene
second
week
diseas
onset
tabl
result
suggest
exist
hypercytokinemia
dynam
induc
viru
cytokin
chemokin
level
relat
sever
diseas
apach
ii
score
use
evalu
sever
diseas
first
day
patient
admit
intens
care
unit
icu
plasma
level
scf
hgf
mif
mig
week
week
diseas
onset
show
high
signific
posit
linear
correl
apach
ii
score
tabl
supplement
figur
level
hgf
scf
mig
plasma
sampl
obtain
first
week
diseas
onset
especi
highli
associ
diseas
sever
indic
molecul
could
serv
biomark
earli
stage
infect
tabl
supplement
figur
result
suggest
hypercytokinemia
dynam
cytokin
chemokin
plasma
level
predict
fatal
outcom
analyz
whether
plasma
cytokin
chemokin
level
link
fatal
outcom
note
plasma
level
hgf
mif
scf
second
week
diseas
found
significantli
higher
patient
die
patient
left
hospit
within
day
fig
supplement
tabl
statist
link
independ
inflammatori
mediat
predict
fatal
outcom
calcul
area
curv
auc
receiv
oper
characterist
roc
curv
elev
cytokin
chemokin
induc
infect
supplement
tabl
auc
valu
roc
curv
mif
scf
hgf
signific
p
valu
fig
supplement
tabl
therefor
level
identifi
protein
plasma
sampl
harvest
patient
infect
second
week
diseas
onset
could
predict
fatal
outcom
p
valu
report
significantli
elev
cytokin
chemokin
plasma
sampl
patient
studi
includ
ngf
mig
ctack
gcsf
gmcsf
vegf
basicfgf
pdgfbb
rant
signific
predict
fatal
outcom
supplement
tabl
result
suggest
level
hypercytokinemia
factor
mif
scf
hgf
biomark
predict
fatal
outcom
patient
also
analyz
logist
regress
outcom
predictor
independ
cytokin
chemokin
harvest
patient
plasma
second
week
diseas
onset
use
genom
mean
fold
chang
hypercytokinemia
factor
level
includ
mif
scf
hgf
plasma
sampl
patient
cytokin
figur
profil
cytokin
chemokin
statist
independ
outcom
predictor
tabl
interest
note
inflammatori
mediat
mif
scf
hgf
play
distinctli
differ
role
immun
respons
mif
chemokin
induc
direct
chemotaxi
regul
function
monocytemacrophag
cell
natur
killer
cell
dendrit
cell
also
call
induc
factor
import
function
known
inhibit
viral
replic
directli
scf
play
import
role
surviv
selfrenew
hematopoiet
stem
cell
hsc
hgf
stimul
regener
epitheli
cell
endotheli
cell
addit
act
hematopoiet
progenitor
cell
plasma
sampl
collect
first
week
diseas
onset
patient
left
hospit
within
day
n
patient
die
n
whose
plasma
sampl
harvest
second
week
diseas
onset
p
p
mechan
may
provid
hypothesi
molecular
base
respons
fatal
outcom
lethal
viru
induc
ard
biomark
requir
independ
cohort
confirm
scf
alreadi
use
major
hospit
china
diagnost
biomark
monitor
diseas
progress
nonsmallcel
lung
cancer
current
dramat
increas
new
case
patient
china
may
pragmat
examin
scf
level
plasma
patient
infect
monitor
sever
diseas
predict
fatal
outcom
high
elev
report
plasma
patient
sarscov
avian
influenza
swineorigin
influenza
viru
infect
compar
cytokin
chemokin
mediat
plasma
patient
avian
influenza
swineorigin
influenza
viru
infect
well
sarscov
infect
report
previous
elev
level
mediat
patient
gener
near
patient
signific
sarscov
swine
flu
patient
nevertheless
comparison
may
disturb
sensit
differ
assay
kit
supplement
tabl
furthermor
lack
report
mif
scf
hgf
elev
lethal
viru
infect
may
due
lack
laboratori
examin
studi
necessari
demonstr
whether
find
studi
could
extend
lethal
viru
infect
clinic
specimen
recruit
patient
infect
patient
infect
healthi
volunt
flowchart
recruit
basic
clinic
characterist
describ
previous
studi
approv
institut
review
board
first
affili
hospit
zhejiang
univers
beij
chaoyang
hospit
china
cdc
declar
helsinki
strictli
follow
method
carri
accord
approv
guidelin
human
pharyng
swab
sputum
specimen
peripher
venou
blood
patient
collect
specimen
tube
hank
buffer
first
day
admiss
throughout
cours
ill
laboratori
confirm
viru
viru
infect
perform
use
protocol
describ
previous
obtain
written
inform
consent
particip
guardian
extract
rna
sampl
use
rneasi
mini
kit
qiagen
germani
within
h
sampl
perform
realtim
rtpcr
experi
use
influenza
viru
subtypespecif
gene
primer
provid
china
cdc
abi
usa
data
analyz
pass
qualiti
control
specimen
ct
valu
consid
posit
specimen
ct
repeat
specimen
repeat
result
also
gave
ct
valu
consid
posit
specimen
undetect
ct
valu
repeat
consid
neg
cytokin
chemokin
measur
statist
analysi
use
mannwhitney
utest
determin
whether
differ
cytokin
chemokin
level
group
statist
signific
assum
valu
pgml
statist
purpos
case
concentr
undetect
use
spearman
rank
correl
coeffici
analysi
analyz
linear
correl
use
benjamini
hochberg
method
control
fals
discoveri
rate
fdr
multipl
test
correct
calcul
roc
curv
predict
analysi
use
logist
regress
analyz
independ
outcom
predictor
mannwhitney
utest
correl
statist
analysi
roc
curv
analysi
logist
regress
perform
use
multipl
test
correct
fdr
valu
calcul
use
softwar
r
p
valu
less
deriv
twotail
test
analys
consid
statist
signific
tabl
logist
regress
analysi
outcom
predictor
independ
patient
infect
week
diseas
onset
cytokinechemokin
geometr
mean
fold
chang
plasma
cytokin
chemokin
level
includ
mif
scf
hgf
coexist
condit
includ
coronari
heart
diseas
chronic
obstruct
pulmonari
diseas
hypertens
diabet
cerebrovascular
diseas
cancer
